Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.

Biochemistry
R Shapiro, B L Vallee

Abstract

The roles of His-13 and His-114 in the ribonucleolytic and angiogenic activities of human angiogenin have been investigated by site-directed mutagenesis. Replacement of either residue by alanine (H13A and H114A) decreases enzymatic activity toward tRNA by at least 10,000-fold and virtually abolishes 10,000-fold and virtually abolishes angiogenic activity in the chick embryo chorioallantoic membrane assay. Both the H13A and H114A mutant proteins compete effectively with angiogenin in the latter assay; only a 5-fold molar excess of H13A over unmodified protein is required for complete inhibition. The His----Ala substitutions, however, do not have any significant effect on the interaction of angiogenin with human placental ribonuclease inhibitor, an extremely potent inhibitor of angiogenin (Ki approximately 7 x 10(-16 M) previously shown to interact with another active-site residue, Lys-40. The effects of more conservative replacements-glutamine at position 13 and asparagine at position 114--were also examined. While the enzymatic activity of the H114N mutant was at least 3300-fold less than for the unmodified protein, the H13Q derivative had only 300-fold reduced activity toward tRNA and cytidylyl(3'----5') adenosine. Both substi...Continue Reading

References

Jun 17, 1986·Biochemistry·R ShapiroB L Vallee
Jan 1, 1987·Nouvelle Revue Française D'hématologie·A Camez, G Tobelem
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R Bicknell, B L Vallee
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J W Harper, B L Vallee
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R Bicknell, B L Vallee
Feb 1, 1989·Molecular and Biochemical Parasitology·C E Clayton, J A Fox
May 30, 1989·Biochemical and Biophysical Research Communications·F S Lee, B L Vallee
Sep 24, 1985·Biochemistry·D J StrydomB L Vallee
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R ShapiroB L Vallee
Oct 14, 1988·Biochemical and Biophysical Research Communications·R ShapiroB L Vallee
Aug 23, 1988·Biochemistry·K KurachiB L Vallee
Jun 5, 1987·Science·J R Knowles
Apr 19, 1988·Biochemistry·A WlodawerG L Gilliland
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R Shapiro, B L Vallee
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D K St ClairB L Vallee
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T A Kunkel
Jan 1, 1969·Annual Review of Biochemistry·E A Barnard
Apr 1, 1969·Proceedings of the National Academy of Sciences of the United States of America·G C RobertsO Jardetzky
May 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·A Wlodawer, L Sjölin
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A WlodawerL Sjölin

❮ Previous
Next ❯

Citations

Jun 1, 1994·Journal of Computer-aided Molecular Design·B J HowlinG A Webb
Mar 27, 2012·Translational Stroke Research·Michelle T L NgBrian K Kwon
Dec 20, 1992·Journal of Molecular Biology·K R AcharyaB L Vallee
Sep 1, 1994·Pharmacology & Therapeutics·W Auerbach, R Auerbach
Oct 6, 1993·Biochimica Et Biophysica Acta·T P CurranB L Vallee
Jun 8, 2002·Biochemical and Biophysical Research Communications·Zheng-ping XuGuo-fu Hu
Aug 12, 1999·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·J SoucekS A Benner
Feb 5, 2003·Bioorganic & Medicinal Chemistry Letters·Joshua J HigginRonald T Raines
Jun 1, 1994·Journal of the American Chemical Society·J E Thompson, R T Raines
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·T W HallahanB L Vallee
Mar 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G F HuB L Vallee
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F Soncin
Feb 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·G F HuB L Vallee
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J MoroianuB L Vallee
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·J RoyoE Newbigin
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·J Moroianu, J F Riordan
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·K R AcharyaB L Vallee
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·N RussoB L Vallee
Jan 17, 1995·Proceedings of the National Academy of Sciences of the United States of America·K A OlsonB L Vallee
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·K R AcharyaB L Vallee
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·N RussoR Shapiro
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·N RussoB L Vallee
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·V NobileR Shapiro
Sep 3, 1999·Nucleic Acids Research·B R KelemenR T Raines
Dec 24, 1998·Nucleic Acids Research·E C Scott, O C Uhlenbeck
Mar 1, 2008·Protein Engineering, Design & Selection : PEDS·Bryan D Smith, Ronald T Raines
Nov 23, 2005·Acta Crystallographica. Section D, Biological Crystallography·Daniel E HollowayK Ravi Acharya
Jul 27, 2001·Protein Science : a Publication of the Protein Society·D D LeonidasK R Acharya
Oct 19, 2010·BMC Evolutionary Biology·Francisco M CodoñerMario A Fares
Sep 22, 2007·BMC Evolutionary Biology·Daniel S OsorioMaria J Ramos
Jun 1, 1997·Pediatric Research·A Malamitsi-PuchnerI Phocas
Jul 30, 1997·Biochemical and Biophysical Research Communications·F SoncinJ Badet
Jul 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Richard Y T KaoRobert Shapiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.